CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)	Preferred Stock [Member] Series A Preferred Stock	Preferred Stock [Member] Series T Preferred Stock	Preferred Stock [Member] Series Seed Preferred Stock	Common Stock	Additional Paid-in Capital	Noncontrolling Interest [Member]	Retained Earnings [Member]	Total
Balance at the beginning at Dec. 31, 2022	$ 5,286,667	$ 983,634	$ 1,706,756	$ 6,660	$ 45,418,943	$ (13,251)	$ (28,261,951)	$ 25,127,458
Balance at the beginning (in shares) at Dec. 31, 2022	185,440,880	9,642,080	204,810,720	666,033,240
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Sale of common stock				$ 12	1,124,508			1,124,520
Sale of common stock (in shares)				1,184,700
Offering Costs					(770,651)			(770,651)
Exercise of stock options				$ 23	20,971			20,994
Exercise of stock options (in shares)				2,261,600
Stock compensation expense					897,634			897,634
Net Income (Loss)							(2,536,916)	(2,536,916)
Balance at the end at Mar. 31, 2023	$ 5,286,667	$ 983,634	$ 1,706,756	$ 6,695	46,691,405	(13,251)	(30,798,867)	23,863,039
Balance at the end (in shares) at Mar. 31, 2023	185,440,880	9,642,080	204,810,720	669,479,540
Balance at the beginning at Dec. 31, 2022	$ 5,286,667	$ 983,634	$ 1,706,756	$ 6,660	45,418,943	(13,251)	(28,261,951)	$ 25,127,458
Balance at the beginning (in shares) at Dec. 31, 2022	185,440,880	9,642,080	204,810,720	666,033,240
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Sale of common stock (in shares)								5,212,360
Net Income (Loss)								$ (10,562,315)
Balance at the end at Sep. 30, 2023	$ 5,286,667	$ 983,634	$ 1,706,756	$ 6,733	77,438,025	(13,251)	(38,824,266)	46,584,298
Balance at the end (in shares) at Sep. 30, 2023	185,440,880	9,642,080	204,810,720	693,116,200
Balance at the beginning at Mar. 31, 2023	$ 5,286,667	$ 983,634	$ 1,706,756	$ 6,695	46,691,405	(13,251)	(30,798,867)	23,863,039
Balance at the beginning (in shares) at Mar. 31, 2023	185,440,880	9,642,080	204,810,720	669,479,540
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Sale of common stock				$ 1	1,900,454			1,900,455
Sale of common stock (in shares)				1,702,900
Offering Costs					(802,248)			(802,248)
Exercise of stock options					375			375
Exercise of stock options (in shares)				2,000
Stock compensation expense					1,927,283			1,927,283
SeedInvest Acquistion				$ 10	23,999,990			24,000,000
SeedInvest Acquistion (in shares)				19,200,000
Net Income (Loss)							(3,575,868)	(3,575,868)
Balance at the end at Jun. 30, 2023	$ 5,286,667	$ 983,634	$ 1,706,756	$ 6,706	73,717,259	(13,251)	(34,374,735)	47,313,036
Balance at the end (in shares) at Jun. 30, 2023	185,440,880	9,642,080	204,810,720	690,384,440
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Sale of common stock				$ 23	2,617,675			2,617,698
Sale of common stock (in shares)				2,324,760
Offering Costs					(1,028,345)			(1,028,345)
Exercise of stock options				$ 4	50,871			50,875
Exercise of stock options (in shares)				407,000
Stock compensation expense					2,080,565			2,080,565
Net Income (Loss)							(4,449,531)	(4,449,531)
Balance at the end at Sep. 30, 2023	$ 5,286,667	$ 983,634	$ 1,706,756	$ 6,733	77,438,025	(13,251)	(38,824,266)	46,584,298
Balance at the end (in shares) at Sep. 30, 2023	185,440,880	9,642,080	204,810,720	693,116,200
Balance at the beginning at Dec. 31, 2023	$ 5,286,667	$ 983,634	$ 1,706,756	$ 6,971	82,005,447	(13,251)	(44,637,430)	45,338,794
Balance at the beginning (in shares) at Dec. 31, 2023	185,440,880	9,642,080	204,810,720	697,085,900
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Sale of common stock				$ 2	201,124			201,126
Sale of common stock (in shares)				177,980
Stock compensation expense					2,666,169			2,666,169
Net Income (Loss)							(4,020,586)	(4,020,586)
Balance at the end at Mar. 31, 2024	$ 5,286,667	$ 983,634	$ 1,706,756	$ 6,973	84,872,740	(13,251)	(48,658,016)	44,185,503
Balance at the end (in shares) at Mar. 31, 2024	185,440,880	9,642,080	204,810,720	697,263,880
Balance at the beginning at Dec. 31, 2023	$ 5,286,667	$ 983,634	$ 1,706,756	$ 6,971	82,005,447	(13,251)	(44,637,430)	$ 45,338,794
Balance at the beginning (in shares) at Dec. 31, 2023	185,440,880	9,642,080	204,810,720	697,085,900
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Sale of common stock (in shares)								177,982
Net Income (Loss)								$ (13,828,694)
Balance at the end at Sep. 30, 2024	$ 5,286,667	$ 983,634	$ 1,706,756	$ 7,006	90,496,349	(13,251)	(58,466,124)	40,001,037
Balance at the end (in shares) at Sep. 30, 2024	185,440,880	9,642,080	204,810,720	700,622,717
Balance at the beginning at Mar. 31, 2024	$ 5,286,667	$ 983,634	$ 1,706,756	$ 6,973	84,872,740	(13,251)	(48,658,016)	44,185,503
Balance at the beginning (in shares) at Mar. 31, 2024	185,440,880	9,642,080	204,810,720	697,263,880
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Sale of common stock					350			350
Exercise of stock options				$ 6	13,959			13,965
Exercise of stock options (in shares)				648,360
Stock compensation expense					2,653,745			2,653,745
Net Income (Loss)							(3,022,144)	(3,022,144)
Balance at the end at Jun. 30, 2024	$ 5,286,667	$ 983,634	$ 1,706,756	$ 6,979	87,540,794	(13,251)	(51,680,160)	43,831,419
Balance at the end (in shares) at Jun. 30, 2024	185,440,880	9,642,080	204,810,720	697,912,240
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options				$ 27	27,008			27,035
Exercise of stock options (in shares)				2,710,477
Stock compensation expense					2,928,547			2,928,547
Net Income (Loss)							(6,785,964)	(6,785,964)
Balance at the end at Sep. 30, 2024	$ 5,286,667	$ 983,634	$ 1,706,756	$ 7,006	$ 90,496,349	$ (13,251)	$ (58,466,124)	$ 40,001,037
Balance at the end (in shares) at Sep. 30, 2024	185,440,880	9,642,080	204,810,720	700,622,717